Search
for
Sort by
Research 30 of 132
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Enzalutamide/finasteride/goserelin/zoledronic-acid
- Androgenic Effects on Ventricular Repolarization
- Redefining hormone resistance in prostate cancer
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis
- Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro
- Restricted effects of androgens on glucocorticoid signaling in the mouse prefrontal cortex and midbrain
- Androgen Receptor Blockade Induces the Phagocytosis of MRSA and Pseudomonas aeruginosa by Monocyte-Derived Macrophages In Vitro
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Anogenital distance as a biomarker for incomplete masculinization : Molecular mechanisms in the perineum
- P6590Androgenic effects on ventricular repolarization: a translational study from pharmacovigilance databases to iPSC-cardiomyocytes
- Antiandrogens
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Alopecia With Endocrine Therapies in Patients With Cancer
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection